333 related articles for article (PubMed ID: 33837392)
1. Broad Severe Acute Respiratory Syndrome Coronavirus 2 Cell Tropism and Immunopathology in Lung Tissues From Fatal Coronavirus Disease 2019.
Ramos da Silva S; Ju E; Meng W; Paniz Mondolfi AE; Dacic S; Green A; Bryce C; Grimes Z; Fowkes M; Sordillo EM; Cordon-Cardo C; Guo H; Gao SJ
J Infect Dis; 2021 Jun; 223(11):1842-1854. PubMed ID: 33837392
[TBL] [Abstract][Full Text] [Related]
2. Infectious Clones Produce SARS-CoV-2 That Causes Severe Pulmonary Disease in Infected K18-Human ACE2 Mice.
Liu X; Zaid A; Freitas JR; McMillan NA; Mahalingam S; Taylor A
mBio; 2021 Apr; 12(2):. PubMed ID: 33879586
[TBL] [Abstract][Full Text] [Related]
3. Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Replication and Tropism in the Lungs, Airways, and Vascular Endothelium of Patients With Fatal Coronavirus Disease 2019: An Autopsy Case Series.
Bhatnagar J; Gary J; Reagan-Steiner S; Estetter LB; Tong S; Tao Y; Denison AM; Lee E; DeLeon-Carnes M; Li Y; Uehara A; Paden CR; Leitgeb B; Uyeki TM; Martines RB; Ritter JM; Paddock CD; Shieh WJ; Zaki SR
J Infect Dis; 2021 Mar; 223(5):752-764. PubMed ID: 33502471
[TBL] [Abstract][Full Text] [Related]
4. Immunological Aspects of SARS-CoV-2 Infection and the Putative Beneficial Role of Vitamin-D.
Peng MY; Liu WC; Zheng JQ; Lu CL; Hou YC; Zheng CM; Song JY; Lu KC; Chao YC
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34065735
[TBL] [Abstract][Full Text] [Related]
5. Tissue-Specific Immunopathology in Fatal COVID-19.
Dorward DA; Russell CD; Um IH; Elshani M; Armstrong SD; Penrice-Randal R; Millar T; Lerpiniere CEB; Tagliavini G; Hartley CS; Randle NP; Gachanja NN; Potey PMD; Dong X; Anderson AM; Campbell VL; Duguid AJ; Al Qsous W; BouHaidar R; Baillie JK; Dhaliwal K; Wallace WA; Bellamy COC; Prost S; Smith C; Hiscox JA; Harrison DJ; Lucas CD
Am J Respir Crit Care Med; 2021 Jan; 203(2):192-201. PubMed ID: 33217246
[No Abstract] [Full Text] [Related]
6. [Comparison of clinical and pathological features between severe acute respiratory syndrome and coronavirus disease 2019].
Zhang T; Sun LX; Feng RE
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Jun; 43(6):496-502. PubMed ID: 32241072
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients.
Chen H; Liu W; Wang Y; Liu D; Zhao L; Yu J
EBioMedicine; 2021 Aug; 70():103500. PubMed ID: 34311326
[TBL] [Abstract][Full Text] [Related]
8. COVID-19 Lung Pathogenesis in SARS-CoV-2 Autopsy Cases.
Valdebenito S; Bessis S; Annane D; Lorin de la Grandmaison G; Cramer-Bordé E; Prideaux B; Eugenin EA; Bomsel M
Front Immunol; 2021; 12():735922. PubMed ID: 34671353
[TBL] [Abstract][Full Text] [Related]
9. Host metabolism dysregulation and cell tropism identification in human airway and alveolar organoids upon SARS-CoV-2 infection.
Pei R; Feng J; Zhang Y; Sun H; Li L; Yang X; He J; Xiao S; Xiong J; Lin Y; Wen K; Zhou H; Chen J; Rong Z; Chen X
Protein Cell; 2021 Sep; 12(9):717-733. PubMed ID: 33314005
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 Infection and Disease Modelling Using Stem Cell Technology and Organoids.
Trevisan M; Riccetti S; Sinigaglia A; Barzon L
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652988
[TBL] [Abstract][Full Text] [Related]
11. Human lungs show limited permissiveness for SARS-CoV-2 due to scarce ACE2 levels but virus-induced expansion of inflammatory macrophages.
Hönzke K; Obermayer B; Mache C; Fatykhova D; Kessler M; Dökel S; Wyler E; Baumgardt M; Löwa A; Hoffmann K; Graff P; Schulze J; Mieth M; Hellwig K; Demir Z; Biere B; Brunotte L; Mecate-Zambrano A; Bushe J; Dohmen M; Hinze C; Elezkurtaj S; Tönnies M; Bauer TT; Eggeling S; Tran HL; Schneider P; Neudecker J; Rückert JC; Schmidt-Ott KM; Busch J; Klauschen F; Horst D; Radbruch H; Radke J; Heppner F; Corman VM; Niemeyer D; Müller MA; Goffinet C; Mothes R; Pascual-Reguant A; Hauser AE; Beule D; Landthaler M; Ludwig S; Suttorp N; Witzenrath M; Gruber AD; Drosten C; Sander LE; Wolff T; Hippenstiel S; Hocke AC
Eur Respir J; 2022 Dec; 60(6):. PubMed ID: 35728978
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study.
Carsana L; Sonzogni A; Nasr A; Rossi RS; Pellegrinelli A; Zerbi P; Rech R; Colombo R; Antinori S; Corbellino M; Galli M; Catena E; Tosoni A; Gianatti A; Nebuloni M
Lancet Infect Dis; 2020 Oct; 20(10):1135-1140. PubMed ID: 32526193
[TBL] [Abstract][Full Text] [Related]
13. ACE2 protein expression in lung tissues of severe COVID-19 infection.
Gheware A; Ray A; Rana D; Bajpai P; Nambirajan A; Arulselvi S; Mathur P; Trikha A; Arava S; Das P; Mridha AR; Singh G; Soneja M; Nischal N; Lalwani S; Wig N; Sarkar C; Jain D
Sci Rep; 2022 Mar; 12(1):4058. PubMed ID: 35260724
[TBL] [Abstract][Full Text] [Related]
14. Kinetic Multi-omic Analysis of Responses to SARS-CoV-2 Infection in a Model of Severe COVID-19.
Cantwell AM; Singh H; Platt M; Yu Y; Lin YH; Ikeno Y; Hubbard G; Xiang Y; Gonzalez-Juarbe N; Dube PH
J Virol; 2021 Sep; 95(20):e0101021. PubMed ID: 34319784
[TBL] [Abstract][Full Text] [Related]
15. The Spectrum of Histopathologic Findings in Lungs of Patients With Fatal Coronavirus Disease 2019 (COVID-19) Infection.
Roden AC; Bois MC; Johnson TF; Aubry MC; Alexander MP; Hagen CE; Lin PT; Quinton RA; Maleszewski JJ; Boland JM
Arch Pathol Lab Med; 2021 Jan; 145(1):11-21. PubMed ID: 32821902
[TBL] [Abstract][Full Text] [Related]
16. Tissue-based SARS-CoV-2 detection in fatal COVID-19 infections: Sustained direct viral-induced damage is not necessary to drive disease progression.
El Jamal SM; Pujadas E; Ramos I; Bryce C; Grimes ZM; Amanat F; Tsankova NM; Mussa Z; Olson S; Salem F; Miorin L; Aydillo T; Schotsaert M; Albrecht RA; Liu WC; Marjanovic N; Francoeur N; Sebra R; Sealfon SC; García-Sastre A; Fowkes M; Cordon-Cardo C; Westra WH
Hum Pathol; 2021 Aug; 114():110-119. PubMed ID: 33961839
[TBL] [Abstract][Full Text] [Related]
17. Novel insight from the first lung transplant of a COVID-19 patient.
Chen XJ; Li K; Xu L; Yu YJ; Wu B; He YL; Zhao WE; Li D; Luan CX; Hu L; Wang J; Ding JJ; Yu YF; Li JX; Tan ZM; Liu XF; Wei D; Zhang ZH; Guo XJ; Su C; Hu ZB; Guo YS; Chen JY; Chen F
Eur J Clin Invest; 2021 Jan; 51(1):e13443. PubMed ID: 33131070
[TBL] [Abstract][Full Text] [Related]
18. Molecular and immune signatures, and pathological trajectories of fatal COVID-19 lungs defined by in situ spatial single-cell transcriptome analysis.
Das A; Meng W; Liu Z; Hasib MM; Galloway H; Ramos da Silva S; Chen L; Sica GL; Paniz-Mondolfi A; Bryce C; Grimes Z; Sordillo EM; Cordon-Cardo C; Rivera KP; Flores M; Chiu YC; Huang Y; Gao SJ
J Med Virol; 2023 Aug; 95(8):e29009. PubMed ID: 37563850
[TBL] [Abstract][Full Text] [Related]
19. Pathological post-mortem findings in lungs infected with SARS-CoV-2.
Damiani S; Fiorentino M; De Palma A; Foschini MP; Lazzarotto T; Gabrielli L; Viale PL; Attard L; Riefolo M; D'Errico A
J Pathol; 2021 Jan; 253(1):31-40. PubMed ID: 32930394
[TBL] [Abstract][Full Text] [Related]
20. Airway and parenchyma immune cells in influenza A(H1N1)pdm09 viral and non-viral diffuse alveolar damage.
Buttignol M; Pires-Neto RC; Rossi E Silva RC; Albino MB; Dolhnikoff M; Mauad T
Respir Res; 2017 Aug; 18(1):147. PubMed ID: 28774302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
